Skip to main content
SpringerLink
Log in

Rituximab, plerixafor, tocilizumab accepted for use in Scotland

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rituximab, plerixafor, tocilizumab accepted for use in Scotland. Pharmacoecon. Outcomes News 596, 11 (2010). https://doi.org/10.2165/00151234-201005960-00041

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-201005960-00041

Keywords

Search

Navigation